Despite previous reports on NF-κB inhibitors encoded by ASFV, a comprehensive investigation into their mechanisms of action in vitro and in vivo, specifically regarding viral infection and pathogenicity, has not been detailed [42,43]. This evidence concerns the gene NFKB1 and viral infectious disease.